• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.74% Nasdaq Up 0.92%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    5.78 Up 0.15(2.66%) Sep 27, 4:00PM EDT
    Prev Close:5.63
    Open:5.63
    Bid:5.65 x 2600
    Ask:6.50 x 100
    1y Target Est:9.90
    Beta:1.3224
    Earnings Date:Nov 7 - Nov 11 (Est.)
    Day's Range:5.57 - 5.78
    52wk Range:2.50 - 7.15
    Volume:3,106,375
    Avg Vol (3m):2,985,520
    Market Cap:1.04B
    P/E (ttm):N/A
    EPS (ttm):-1.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGYP

    Comparison

    Symbol% ChgMkt Cap
    SGYPUp 2.66%1.04B
    IRWDUp 3.80%2.34B
    SCMPUp 0.23%555.25M
    SLXP 0.00%10.88B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.03
    Quarterly EPS Est (Sep-16) :-0.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback